Journal Article Ppublish 41 citations
PubMed: 37377363 DOI: 10.2214/AJR.23.29342
Use of a Commercial 7-T MRI Scanner for Clinical Brain Imaging: Indications, Protocols, Challenges, and Solutions-A Single-Center Experience.
AJR Am J Roentgenol 221(6):788-804
Authors: Can Özütemiz, Matthew White, Wendy Elvendahl, Yigitcan Eryaman, Małgorzata Marjańska, Gregory J Metzger, Rémi Patriat, Jeramy Kulesa, Noam Harel, Yoichi Watanabe, Andrea Grant, Guglielmo Genovese, Zuzan Cayci
Affiliations
- Department of Radiology, University of Minnesota, 420 Delaware St SE, MMC 292, Minneapolis, MN 55455.
- Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN.
- Center for Clinical Imaging Research, Department of Radiology, University of Minnesota, Minneapolis, MN.
- Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN. Center for Clinical Imaging Research, Department of Radiology, University of Minnesota, Minneapolis, MN.
- Department of Radiation Oncology, University of Minnesota, Minneapolis, MN.
Abstract
The first commercially available 7-T MRI scanner (Magnetom Terra) was approved by the FDA in 2017 for clinical imaging of the brain and knee. After initial protocol development and sequence optimization efforts in volunteers, the 7-T system, in combination with an FDA-approved 1-channel transmit/32-channel receive array head coil, can now be routinely used for clinical brain MRI examinations. The ultrahigh field strength of 7-T MRI has the advantages of improved spatial resolution, increased SNR, and increased CNR but also introduces an array of new technical challenges. The purpose of this article is to describe an institutional experience with the use of the commercially available 7-T MRI scanner for routine clinical brain imaging. Specific clinical indications for which 7-T MRI may be useful for brain imaging include brain tumor evaluation with possible perfusion imaging and/or spectroscopy, radiotherapy planning; evaluation of multiple sclerosis and other demyelinating diseases, evaluation of Parkinson disease and guidance of deep brain stimulator placement, high-detail intracranial MRA and vessel wall imaging, evaluation of pituitary pathology, and evaluation of epilepsy. Detailed protocols, including sequence parameters, for these various indications are presented, and implementation challenges (including artifacts, safety, and side effects) and potential solutions are explored.
MeSH
Parkinson Disease, Brain, Solutions
Cited by
- The use of 7T MRI in multiple sclerosis: review and consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Brain Commun, 2024
- Occult Amyloid-β-Related Angiitis: Neuroimaging Findings at 1.5T, 3T, and 7T MRI. AJNR Am J Neuroradiol, 2024
- On the RF safety of titanium mesh head implants in 7 T MRI systems: an investigation. Magn Reson Med, 2025
- Reevaluating the neural noise in dyslexia using biomarkers from electroencephalography and high-resolution magnetic resonance spectroscopy. Elife, 2025
- Simultaneous whole-brain and cervical spine imaging at 7 T using a neurovascular head and neck coil with 8-channel transceiver array and 56-channel receiver array. Magn Reson Med, 2025
- A 128-channel receive array with enhanced signal-to-noise ratio performance for 10.5T brain imaging. Magn Reson Med, 2025
- RF coil design strategies for improving SNR at the ultrahigh magnetic field of 10.5T. Magn Reson Med, 2024
- DSC MR Perfusion at 7T MRI: An Initial Single-Center Study for Validity and Practicability. AJNR Am J Neuroradiol, 2025
- Comparison of dynamic susceptibility contrast (DSC) using gadolinium and iron-based contrast agents in high-grade glioma at high-field MRI. Neuroradiol J, 2024
- 7T MRI in the evaluation of ischemic stroke: a systematic review. Front Neurosci, 2025
- Prevalence of Rathke Cleft and Other Incidental Pituitary Gland Findings on Contrast-Enhanced 3D Fat-Saturated T1 MPRAGE at 7T MRI. AJNR Am J Neuroradiol, 2024
- Recent Advances in Compact Portable Platforms and Gradient Hardware for Brain MRI. Radiology, 2025
- Neurochemical Profiles of Prefrontal Cortex and Hypothalamus at 3 and 7 T During Controlled Euglycemia: Evaluation in a Cohort With Type 1 Diabetes. NMR Biomed, 2025